Equity Overview
Price & Market Data
Price: $0.12
Daily Change: $0.00 / 0.00%
Daily Range: $0.12 - $0.12
Market Cap: $9,308,616
Daily Volume: 1,210
Performance Metrics
1 Week: 14.39%
1 Month: 990.9%
3 Months: 5.26%
6 Months: 659.5%
1 Year: -82.86%
YTD: 5.26%
About Biomind Labs Inc. (BMNDF)
Financial overview of Biomind Labs Inc. (BMNDF). Current price: 0.12, daily change: $0.00 / 0.00%. Market cap: 9,308,616. Performance YTD, 1-week, 1-month.
Company Details
Employees: 6
Sector: Finance
Industry: Investment banks/Brokers
Country: Uruguay
Details
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine based formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment; BMND06 is in Phase I clinical trial for treatment of morbid obesity; and BMDO9 is in Phase I clinical trial for treatment of Parkinson's disease. It is also developing preclinical drug candidates, including BMND02 for the treatment of fibromyalgia, BMND03 for the treatment of addictive disorders, BMND05 for the treatment of chronic pain, BMND05 for the treatment of inflammatory disorders, and BMND07 for the treatment of major depressive disorder. The company is headquartered in Canelones, Uruguay.